The Potential of Viral Vector-Mediated Gene Transfer to Prolong Corneal Allograft Survival

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|9|1|33-44

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.9, Iss.1, 2009-02, pp. : 33-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Viral Vector-Mediated Gene Therapy for Hemophilia

By  

Current Gene Therapy, Vol. 1, Iss. 3, 2001-09 ,pp. : 301-315

Bentham Science Publishers

Access to resources Recommend Favorite

Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous System

By Pérez-Martínez Francisco   Guerra Javier   Posadas Inmaculada   Ceña Valentín  

Pharmaceutical Research, Vol. 28, Iss. 8, 2011-08 ,pp. : 1843-1858

Springer Publishing Company

Access to resources Recommend Favorite

Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy

By  

Current Gene Therapy, Vol. 1, Iss. 2, 2001-07 ,pp. : 149-162

Bentham Science Publishers

Access to resources Recommend Favorite

The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 381-394

Bentham Science Publishers

Access to resources Recommend Favorite

Viral-Mediated Gene Transfer for Cancer Treatment

By  

Current Pharmaceutical Biotechnology, Vol. 3, Iss. 2, 2002-06 ,pp. : 151-164

Bentham Science Publishers

Access to resources Recommend Favorite